N
NanHua Bio-medicine Co Ltd
SZSE:000504
NanHua Bio-medicine Co Ltd
SZSE:000504
Price:
8.62
CNY
-0.46%
Market Closed
Market Cap:
¥2.8B
Relative Value
The Relative Value of one NanHua Bio-medicine Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 8.62 CNY, NanHua Bio-medicine Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NanHua Bio-medicine Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
NanHua Bio-medicine Co Ltd Competitors
NanHua Bio-medicine Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
N
|
NanHua Bio-medicine Co Ltd
SZSE:000504
|
2.8B CNY | 22.7 | -458.6 | -115.7 | -115.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
405.4B USD | 6.8 | 171.7 | 16.6 | 23.6 | |
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
326.4B USD | 462 374.5 | -2 631.9 | -2 377 | -2 377 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
204.5B USD | 5.6 | 26.7 | 15.2 | 15.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
183B USD | 6.3 | 21.7 | 14.7 | 14.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.8B USD | 10.4 | 31.4 | 24.1 | 25.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.4B USD | 5.8 | 18.3 | 13.9 | 15.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.5B EUR | 14.3 | 33.7 | 57.9 | 59.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70.5B AUD | 3.1 | 16.3 | 11.2 | 14 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
